Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Karin Ribi; Weixiu Luo; Marco Colleoni; Per Karlsson; Jacquie Chirgwin; Stefan Aebi; Guy Jerusalem; Patrick Neven; Vincenzo Di Lauro; Henry L. Gomez; Thomas Ruhstaller; Ehtesham Abdi; Laura Biganzoli; Bettina Müller; Annelore Barbeaux; Marie-Pascale Graas; Manuela Rabaglio; Prudence A. Francis; Theodoros Foukakis; Olivia Pagani; Claudio Graiff; Daniel Vorobiof; Rudolf Maibach; Angelo Di Leo; Richard D. Gelber; Aron Goldhirsch; Alan S. Coates; Meredith M. Regan; Jürg Bernhard

doi:10.1038/s41416-019-0435-4

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Karin Ribi
, Weixiu Luo
, Marco Colleoni
, Per Karlsson
, Jacquie Chirgwin
, Stefan Aebi
, Guy Jerusalem
, Patrick Neven
, Vincenzo Di Lauro
, Henry L. Gomez
, Thomas Ruhstaller
, Ehtesham Abdi
, Laura Biganzoli
, Bettina Müller
, Annelore Barbeaux
, Marie-Pascale Graas
, Manuela Rabaglio
, Prudence A. Francis
, Theodoros Foukakis
, Olivia Pagani

Claudio Graiff, Daniel Vorobiof, Rudolf Maibach, Angelo Di Leo, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, Meredith M. Regan, Jürg Bernhard

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	959-967
Journal	British Journal of Cancer
Volume	120
Issue number	10
DOIs	https://doi.org/10.1038/s41416-019-0435-4
Publication status	Published - 1 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41416-019-0435-4

https://www.nature.com/articles/s41416-019-0435-4

Cite this

Ribi, K., Luo, W., Colleoni, M., Karlsson, P., Chirgwin, J., Aebi, S., Jerusalem, G., Neven, P., Di Lauro, V., Gomez, H. L., Ruhstaller, T., Abdi, E., Biganzoli, L., Müller, B., Barbeaux, A., Graas, M.-P., Rabaglio, M., Francis, P. A., Foukakis, T., ... Bernhard, J. (2019). Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British Journal of Cancer, 120(10), 959-967. https://doi.org/10.1038/s41416-019-0435-4

@article{4d4aaf0673c044ae85b244933e4c894a,

title = "Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial",

author = "Karin Ribi and Weixiu Luo and Marco Colleoni and Per Karlsson and Jacquie Chirgwin and Stefan Aebi and Guy Jerusalem and Patrick Neven and \{Di Lauro\}, Vincenzo and Gomez, \{Henry L.\} and Thomas Ruhstaller and Ehtesham Abdi and Laura Biganzoli and Bettina M{\"u}ller and Annelore Barbeaux and Marie-Pascale Graas and Manuela Rabaglio and Francis, \{Prudence A.\} and Theodoros Foukakis and Olivia Pagani and Claudio Graiff and Daniel Vorobiof and Rudolf Maibach and \{Di Leo\}, Angelo and Gelber, \{Richard D.\} and Aron Goldhirsch and Coates, \{Alan S.\} and Regan, \{Meredith M.\} and J{\"u}rg Bernhard",

year = "2019",

month = may,

day = "1",

doi = "10.1038/s41416-019-0435-4",

language = "English",

volume = "120",

pages = "959--967",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "10",

}

Ribi, K, Luo, W, Colleoni, M, Karlsson, P, Chirgwin, J, Aebi, S, Jerusalem, G, Neven, P, Di Lauro, V, Gomez, HL, Ruhstaller, T, Abdi, E, Biganzoli, L, Müller, B, Barbeaux, A, Graas, M-P, Rabaglio, M, Francis, PA, Foukakis, T, Pagani, O, Graiff, C, Vorobiof, D, Maibach, R, Di Leo, A, Gelber, RD, Goldhirsch, A, Coates, AS, Regan, MM & Bernhard, J 2019, 'Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial', British Journal of Cancer, vol. 120, no. 10, pp. 959-967. https://doi.org/10.1038/s41416-019-0435-4

TY - JOUR

T1 - Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

AU - Ribi, Karin

AU - Luo, Weixiu

AU - Colleoni, Marco

AU - Karlsson, Per

AU - Chirgwin, Jacquie

AU - Aebi, Stefan

AU - Jerusalem, Guy

AU - Neven, Patrick

AU - Di Lauro, Vincenzo

AU - Gomez, Henry L.

AU - Ruhstaller, Thomas

AU - Abdi, Ehtesham

AU - Biganzoli, Laura

AU - Müller, Bettina

AU - Barbeaux, Annelore

AU - Graas, Marie-Pascale

AU - Rabaglio, Manuela

AU - Francis, Prudence A.

AU - Foukakis, Theodoros

AU - Pagani, Olivia

AU - Graiff, Claudio

AU - Vorobiof, Daniel

AU - Maibach, Rudolf

AU - Di Leo, Angelo

AU - Gelber, Richard D.

AU - Goldhirsch, Aron

AU - Coates, Alan S.

AU - Regan, Meredith M.

AU - Bernhard, Jürg

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1038/s41416-019-0435-4

DO - 10.1038/s41416-019-0435-4

M3 - Article

SN - 0007-0920

VL - 120

SP - 959

EP - 967

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 10

ER -